Article
Power and sample size calculations for SNP association studies with censored time-to-event outcomes.
Genetic epidemiology - 1 Sept 2012
Owzar Kouros, Li Zhiguo, Cox Nancy, Jung Sin-Ho
Abstract excerpt
For many clinical studies in cancer, germline DNA is prospectively collected for the purpose of discovering or validating single-nucleotide polymorphisms (SNPs) associated with clinical outcomes. The primary clinical endpoint for many of these studies are time-to-event outcomes such as time of de...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
